Neuropeptides and cytokines seem to modify this association as plasma levels of the neuropeptide orexin-A have been shown to be lower in patients with obesity, but higher in participants with obesity who are more physically active [13], and levels of interleukin (IL-4), IL-10 and IL-13 have been reported to be elevated in participants with low PA [14]. Here, IL13 is linked to obesity disorder.